Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
作者信息
Gautret Philippe, Hoang Van Thuan, Chaudet Hervé, Lagier Jean-Christophe, Raoult Didier
机构信息
IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.
出版信息
Int J Antimicrob Agents. 2021 Jan;57(1):106244. doi: 10.1016/j.ijantimicag.2020.106244.
Abstract
摘要
相似文献
1
Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.羟氯喹啉和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒载量的不确定影响的反应。
Int J Antimicrob Agents. 2021 Jan;57(1):106244. doi: 10.1016/j.ijantimicag.2020.106244.
2
In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.计算机模拟研究阿奇霉素、氯喹和羟氯喹及其对 SARS-CoV-2 感染的潜在作用机制。
Int J Antimicrob Agents. 2020 Sep;56(3):106119. doi: 10.1016/j.ijantimicag.2020.106119. Epub 2020 Jul 30.
3
Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin.过度的羟氯喹和阿奇霉素的溶酶体离子捕获。
Int J Antimicrob Agents. 2020 Jun;55(6):106007. doi: 10.1016/j.ijantimicag.2020.106007. Epub 2020 May 7.
4
The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin.接受羟氯喹和阿奇霉素治疗的新冠肺炎患者的QT间期。
Nat Med. 2020 Jun;26(6):808-809. doi: 10.1038/s41591-020-0888-2.
5
Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection.阿奇霉素在治疗新型冠状病毒肺炎中的其他安全性考量。
CMAJ. 2020 May 4;192(18):E483. doi: 10.1503/cmaj.75427.
6
Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.阿奇霉素联合羟氯喹治疗因 2019 冠状病毒病（COVID-19）入住重症监护病房的患者：随机对照试验 AZIQUINE-ICU 的方案。
Trials. 2020 Jul 8;21(1):631. doi: 10.1186/s13063-020-04566-x.
7
Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolates.SARS-CoV-2 分离株对羟氯喹敏感性的异质性。
Front Biosci (Landmark Ed). 2021 Dec 30;26(12):1493-1502. doi: 10.52586/5043.
8
Does hydroxychloroquine prevent the transmission of COVID-19?羟氯喹能预防新型冠状病毒肺炎的传播吗？
Ann Rheum Dis. 2020 Jun;79(6):e60. doi: 10.1136/annrheumdis-2020-217501. Epub 2020 Apr 15.
9
Azithromycin in patients with COVID-19: Friend or foe?阿奇霉素用于新冠肺炎患者：是友还是敌？
Clin Microbiol Infect. 2021 Jan;27(1):136-137. doi: 10.1016/j.cmi.2020.09.047. Epub 2020 Sep 29.
10
Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.近期文献不支持将羟氯喹与阿奇霉素联合用于治疗COVID-19患者。
Int J Antimicrob Agents. 2021 Jan;57(1):106241. doi: 10.1016/j.ijantimicag.2020.106241.
引用本文的文献
1
Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann.羟氯喹和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒清除的影响：对埃尔韦·塞利格曼的回应
Int J Antimicrob Agents. 2021 Mar;57(3):106306. doi: 10.1016/j.ijantimicag.2021.106306. Epub 2021 Feb 14.
本文引用的文献
1
Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.羟氯喹和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒载量的影响尚不确定。
Int J Antimicrob Agents. 2021 Jan;57(1):106169. doi: 10.1016/j.ijantimicag.2020.106169.
2
Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China.2019 - 2020年疫情期间的新型冠状病毒感染：重症监护病房的准备——中国四川省的经验
Intensive Care Med. 2020 Feb;46(2):357-360. doi: 10.1007/s00134-020-05954-2. Epub 2020 Feb 5.
Zotero 插件